| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/17/2008 | US20080170992 such as Positron Emitting Tomography (PET) or Single Photon Emission Computed Tomography (SPECT) for detecting angiogenesis in solid tumors; cyclic peptide based on 2,5,8,11,14-pentaoxo-1,4,7,10,13-pentaazacyclopentadecane ring having carboxymethyl, guanidine and radionuclide-containing side chains |
| 07/17/2008 | US20080170991 Selectively targeted antimicrobial peptides and the use thereof |
| 07/17/2008 | US20080169215 Cosmetic compositions |
| 07/17/2008 | DE4393381B4 PTH-Verbindungen mit PTH-ähnlicher Aktivität, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Zusammensetzungen und deren Verwendungen PTH compounds having PTH-like activity, to processes for their preparation, pharmaceutical compositions containing them and their uses |
| 07/17/2008 | DE102007002386A1 Pharmazeutisch wirksame Verbindungen Pharmaceutically active compounds |
| 07/17/2008 | CA2689296A1 Polypeptide inhibitors of hsp27 kinase and uses therefor |
| 07/17/2008 | CA2679563A1 Macrocyclic hepatitis c protease inhibitors |
| 07/17/2008 | CA2675379A1 Protective proteins of s. agalactiae, combinations thereof and methods of using the same |
| 07/17/2008 | CA2675231A1 A conjugate comprising angiostatin or its fragment, the method for producing the conjugate and use thereof |
| 07/17/2008 | CA2675115A1 Lactococcus promoters and uses thereof |
| 07/17/2008 | CA2675029A1 Pharmaceutically active compounds |
| 07/17/2008 | CA2674849A1 Acid ceramidase and cell survival |
| 07/17/2008 | CA2674603A1 Sp35 antibodies and uses thereof |
| 07/17/2008 | CA2674493A1 Compositions of and methods of using sulfatases from flavobacterium heparinum |
| 07/17/2008 | CA2674378A1 Methods and compositions related to clot binding compounds |
| 07/17/2008 | CA2674368A1 Treatment of respiratory chain disorders using compounds having erythropoietin or thrombopoietin activity |
| 07/17/2008 | CA2674315A1 Use of mage a3-protein d fusion antigen in immunotherapy combined with surgery, chemotherapy or radiotherapy for the treatment of cancer |
| 07/17/2008 | CA2674296A1 Non-immunosuppressive cyclosporin for treatment of ullrich congenital muscular dystrophy |
| 07/17/2008 | CA2673972A1 Dbait and its standalone uses thereof |
| 07/17/2008 | CA2673803A1 Compounds and compositions as channel activating protease inhibitors |
| 07/17/2008 | CA2673791A1 Cecropin b and hb-107 derived short bio-active peptides for cellular immune modulation |
| 07/17/2008 | CA2672739A1 Methods of using il-31 to treat airway hyper-responsiveness and asthma |
| 07/16/2008 | EP1944610A1 Engineering affinity ligands for macromolecules |
| 07/16/2008 | EP1944371A2 Neisseria meningitidis antigens and compositions |
| 07/16/2008 | EP1944370A1 New voltage-dependent potassium channel and its use to develop therapeutic medicine |
| 07/16/2008 | EP1944369A1 Dbait and its standalone uses thereof |
| 07/16/2008 | EP1944318A1 Novel multifunctional cytokines |
| 07/16/2008 | EP1944317A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/16/2008 | EP1944312A1 Peptides that specifically bind HGF receptor (CMET) and uses thereof |
| 07/16/2008 | EP1944042A1 Combinations for HCV treatment |
| 07/16/2008 | EP1944037A1 Remedy for mastitis |
| 07/16/2008 | EP1944036A2 Improvements in and relating to drug delivery |
| 07/16/2008 | EP1944016A1 Propellant-based microparticle formulatons |
| 07/16/2008 | EP1943350A2 Latent procytotoxins and uses thereof |
| 07/16/2008 | EP1943342A1 Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications |
| 07/16/2008 | EP1943337A1 Platelet aggregation inhibitor composition |
| 07/16/2008 | EP1943277A2 Anti-thrombotic agents |
| 07/16/2008 | EP1943275A1 Insulinotropic compounds and uses thereof |
| 07/16/2008 | EP1943274A2 Treatment of diabetes related obesity |
| 07/16/2008 | EP1943268A1 Use of the gonadotropin-releasing hormone ii antagonists and its analogues |
| 07/16/2008 | EP1943267A1 A process for the preparation of perindopril erbumine |
| 07/16/2008 | EP1942947A2 Fibronectin polypeptides and methods of use |
| 07/16/2008 | EP1942944A2 Macrocyclic depsipeptide antibody-drug conjugates and methods |
| 07/16/2008 | EP1942930A2 Enzyme inhibitors of pai-1 |
| 07/16/2008 | EP1942928A2 Protein composition for promoting wound healing and skin regeneration |
| 07/16/2008 | EP1942927A2 Method for discovering inhibitors of the epstein-barr virus-induced gene 3 (ebi3) and derivatives thereof for the treatment of metastasizing tumors and allergic asthma |
| 07/16/2008 | EP1942926A2 Stem cell factor-like protein scfa1 and uses thereof |
| 07/16/2008 | EP1942925A2 Methods for fusion polypeptide delivery into a cell |
| 07/16/2008 | EP1942924A2 Use of vaccines for the treatment/prevention of the transmission of influenza pathogens between species |
| 07/16/2008 | EP1942923A1 Agonist peptides of basic fibroblast growth factor (bfgf) and the method of reduction of wrinkle on skin, darkening of hair and acceleration of wound healing |
| 07/16/2008 | EP1942922A2 Use of complement pathway inhibitors to treat ocular diseases |
| 07/16/2008 | EP1942918A1 Black tea polyphenols and uses thereof |
| 07/16/2008 | EP1942887A1 Tacrolimus combination products |
| 07/16/2008 | EP1942868A2 Sodium chloride solution for drug reconstitution or dilution |
| 07/16/2008 | EP1856533A4 Microglia facilitated amyloidogenesis assay |
| 07/16/2008 | EP1687426B1 Antiangiogenicpeptides for treating or preventing endometriosis |
| 07/16/2008 | EP1687011B1 Modified whole cell, cell extract and omv-based vaccines |
| 07/16/2008 | EP1581812B1 Compositions and methods for diagnosing and treating colon cancers |
| 07/16/2008 | EP1572739B1 Asthma susceptibility locus |
| 07/16/2008 | EP1549358A4 Composition for filling bone defects |
| 07/16/2008 | EP1507865B1 The frog prince, a transposon vector for gene transfer in vertebrates |
| 07/16/2008 | EP1476541B1 Cytokine (zcytor17 ligand) |
| 07/16/2008 | EP1401490B1 Tsg101 as inhibitor of hiv production |
| 07/16/2008 | EP1379882B1 Diagnostic and therapeutic use of a nuclear restricted protein for alzheimer's disease and related neurodegenerative disorders |
| 07/16/2008 | EP1339850B1 A novel cocoa albumin and its use in the production of cocoa and chocolate flavour |
| 07/16/2008 | EP1337548B1 Anti-angiogenic polypeptides |
| 07/16/2008 | EP1337270B1 Long-acting interferon and interlukin derivatives and pharmaceutical compositions comprising them |
| 07/16/2008 | EP1313440B1 Dental products comprising bone growth enhancing peptide |
| 07/16/2008 | EP1311542B1 Tolerogenic peptides |
| 07/16/2008 | EP1305006B1 Process for the manufacture of dispersions for formulating slightly or poorly soluble active ingredients |
| 07/16/2008 | EP1296655B1 Endoparasiticidal agents for voluntary oral ingestion by animals |
| 07/16/2008 | EP1292674B1 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate |
| 07/16/2008 | EP1289542B1 Means for maintenance and/or correction of glucose concentration in blood |
| 07/16/2008 | EP1180123B1 Immunoconjugates having high binding affinity |
| 07/16/2008 | EP1090122B1 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses |
| 07/16/2008 | EP1051479B1 Novel steroid-activated nuclear receptors and uses therefor |
| 07/16/2008 | EP1012277B1 Syndecan interacting proteins and the use thereof |
| 07/16/2008 | EP0951551B1 Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily |
| 07/16/2008 | EP0748377B1 IMPROVED DNase LIQUID SOLUTIONS |
| 07/16/2008 | CN101223443A Method for evaluating the effects of smoke on bronchioles |
| 07/16/2008 | CN101223421A Oral drug delivery system and methods of use thereof |
| 07/16/2008 | CN101223274A Novel phospholipid processing agent |
| 07/16/2008 | CN101223187A New peptides useful as dual caspase-2/-6 inhibitors and their biological applications |
| 07/16/2008 | CN101222934A Methods and systems for neural maintenance and regeneration |
| 07/16/2008 | CN101222933A Semi-synthetic glycopeptides with antibiotic activity |
| 07/16/2008 | CN101220361A Representation method for recombinant american cockroaches allergen protein |
| 07/16/2008 | CN101220092A Human keratinized cell growth factor-1 analogue preparation method and application thereof |
| 07/16/2008 | CN101220089A Chinese South China sea signal conus neurotoxin gene Lt3.1 and uses thereof |
| 07/16/2008 | CN101220088A Amalgamation protein of human glucagons-like peptide-1and uses thereof |
| 07/16/2008 | CN101220083A Synthetic polypeptide and uses thereof |
| 07/16/2008 | CN101219219A Complex containing vascellum chalone or its fragment, preparation method and application thereof |
| 07/16/2008 | CN101219213A Medical preparations for the treatment of alpha-galactosidase a deficiency |
| 07/16/2008 | CN101219212A Eatable face pack for beauty treatment skin-protection and technique of preparing the same |
| 07/16/2008 | CN101219211A Compound polypeptide composition, preparing method and uses of the same |
| 07/16/2008 | CN101219210A Agent kit containing oral insulin solid therapy |
| 07/16/2008 | CN101219209A Insulin-protamine zinc injection and method for preparing the same |
| 07/16/2008 | CN101219208A Medicine use of interleukin-22 |
| 07/16/2008 | CN101219207A Application of recombined human vascellum esoderma inhibin in medicine preparation |
| 07/16/2008 | CN101219206A Application of recombined human vascellum esoderma inhibin in medicine preparation |
| 07/16/2008 | CN101219205A Compounds and methods for treatment and diagnosis of chlamydial infection |